Adenosine deaminase activity in chronic lymphocytic leukemia: evaluation of lymphocytic ADA during and after treatment. 1983

V Liso, and G Specchia, and V Pavone, and P Garribba, and A Riezzo, and A Ferrannini

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009700 Nucleoside Deaminases Catalyze the hydrolysis of nucleosides with the elimination of ammonia. Deaminases, Nucleoside
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000243 Adenosine Deaminase An enzyme that catalyzes the hydrolysis of ADENOSINE to INOSINE with the elimination of AMMONIA. Adenosine Aminohydrolase,Aminohydrolase, Adenosine,Deaminase, Adenosine
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent

Related Publications

V Liso, and G Specchia, and V Pavone, and P Garribba, and A Riezzo, and A Ferrannini
June 2016, Iranian journal of cancer prevention,
V Liso, and G Specchia, and V Pavone, and P Garribba, and A Riezzo, and A Ferrannini
January 1984, Advances in experimental medicine and biology,
V Liso, and G Specchia, and V Pavone, and P Garribba, and A Riezzo, and A Ferrannini
January 1992, Clinical and experimental dermatology,
V Liso, and G Specchia, and V Pavone, and P Garribba, and A Riezzo, and A Ferrannini
November 1985, [Rinsho ketsueki] The Japanese journal of clinical hematology,
V Liso, and G Specchia, and V Pavone, and P Garribba, and A Riezzo, and A Ferrannini
May 1985, American journal of hematology,
V Liso, and G Specchia, and V Pavone, and P Garribba, and A Riezzo, and A Ferrannini
April 1986, American journal of hematology,
V Liso, and G Specchia, and V Pavone, and P Garribba, and A Riezzo, and A Ferrannini
March 1976, The Journal of clinical investigation,
V Liso, and G Specchia, and V Pavone, and P Garribba, and A Riezzo, and A Ferrannini
January 1992, Scandinavian journal of infectious diseases,
V Liso, and G Specchia, and V Pavone, and P Garribba, and A Riezzo, and A Ferrannini
August 1979, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
V Liso, and G Specchia, and V Pavone, and P Garribba, and A Riezzo, and A Ferrannini
January 1977, Advances in experimental medicine and biology,
Copied contents to your clipboard!